Concepedia

Author

Mark Laible

BioNTech (Germany)ORCID

Also Known As

Laible, M., Laible, Mark, M Laible, M. Laible, Mark Laible

50

Publications

599

Citations

14

H-Index

10

Concepts

All Affiliations

BioNTech (Germany)Heidelberg UniversityUniversity Hospital HeidelbergFriedrich-Alexander-Universität Erlangen-NürnbergGerman Cancer Research Center
ML

About

Mark Laible is an author at BioNTech (Germany) specializing in cancer research, urology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

31

2

Cell Biology

1

1

31

3

Cancer Genetics

1

1

31

4

Molecular Oncology

1

1

31

5

Tumor Biology

1

1

31

Mark Laible

×

15

Publications

573

Citations

14

H-Index

YearCitations

Genome-wide DNA Methylation Events in <i>TMPRSS2–ERG</i> Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with <i>miR-26a</i> Hypermethylation

Stefan T. Börno, Axel Fischer, Martin Kerick,

Cancer Discovery

2012

134

Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

Hans‐Peter Sinn, Andreas Schneeweiß, Marius Keller,

BMC Cancer

2017

87

Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens

Mark Laible, Kornelia Schlombs, Katharina Kaiser,

BMC Cancer

2016

54

An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®

Zsuzsanna Varga, Annette Lebeau, Hong Bu,

Breast Cancer Research

2017

39

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry

Ralph M. Wirtz, Harri Sihto, Jorma Isola,

Breast Cancer Research and Treatment

2016

37

ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ

Johannes Breyer, Wolfgang Otto, Ralph M. Wirtz,

Urologia Internationalis

2016

37

ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC)

Johannes Breyer, Ralph M. Wirtz, Mark Laible,

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

2016

31

ERG Induces Epigenetic Activation of Tudor Domain-Containing Protein 1 (TDRD1) in ERG Rearrangement-Positive Prostate Cancer

Lukasz A. Kacprzyk, Mark Laible, Tatjana Andrasiuk,

PLoS ONE

2013

30

<i>TMPRSS2:ERG</i>gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells

Leonie Ratz, Mark Laible, Lukasz A. Kacprzyk,

Oncotarget

2017

28

The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis

Adrian Georg Simon, Su Ir Lyu, Mark Laible,

Journal of Translational Medicine

2023

22

Page 1